Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap42.36B
Enterprise Value55.30B
Trailing P/E60.26
TEVA
(NYSE)Teva Pharmaceutical Industries Limited
$36.85-- (--)
Loading... - Market loading
Teva Pharmaceutical Industries (TEVA) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)2.45
Forward Price/Sales2.35
Price/Book (mrq)5.46
Price/FCF (ttm)31.42
Price/OCF (ttm)22.32
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.19
EV/Earnings78.66
EV/EBITDA20.87
EV/EBIT35.45
EV/FCF41.02
Stock Price
Current price, 52-week range, and moving averages
Current Price$36.76
1-Day Change1.10%
52-Week High$38.37
52-Week Low$18.21
52-Week Change90.47%
YTD Change18.77%
1-Year Change86.79%
50-Day MA$34.69
200-Day MA$32.63
Avg Volume (30 day)5.63M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding1.17B
Book Value per Share$6.66
Net Cash per Share$-11.10
FCF per Share$1.16
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$40.67
Target Upside/Downside10.64%
Analyst ConsensusBuy
Analyst Count7
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin52.47%
EBITDA Margin (ttm)15.31%
EBIT Margin (ttm)9.01%
Operating Margin (ttm)15.47%
Pretax Margin (ttm)4.09%
Profit Margin (ttm)4.06%
FCF Margin (ttm)7.79%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)9.06%
Return on Assets (ttm)1.76%
Return on Invested Capital (ttm)7.49%
Return on Capital Employed (ttm)6.44%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue17.31B
Gross Profit9.09B
Operating Income2.68B
Pretax Income708.00M
Net Income703.00M
EBITDA2.65B
EBIT1.56B
Diluted EPS$0.60
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow1.90B
Capital Expenditures550.00M
Free Cash Flow1.35B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth4.13%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)39.86B
Cash & Securities (mrq)3.65B
Net Cash (mrq)-12.94B
Net Cash per Share$-11.10
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)16.59B
Working Capital (mrq)-1.89B
Total Equity (mrq)7.76B
Book Value per Share$6.66
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)0.88
Quick Ratio (mrq)0.67
Debt/Equity (mrq)2.14
Debt/EBITDA (ttm)6.26
Debt/FCF (ttm)12.31
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Ex-Dividend DateNov 27, 2017
Pay DateDec 12, 2017
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield1.66%
FCF Yield3.18%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-0.94
Piotroski F-Score8/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$9.49
Graham Upside/Downside-74.19%
Frequently Asked Questions About Teva Pharmaceutical Industries Statistics
What are the key financial metrics for TEVA?
Teva Pharmaceutical Industries Limited (TEVA) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is TEVA's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Teva Pharmaceutical Industries is overvalued or undervalued.
How do I read TEVA's profitability ratios?
Teva Pharmaceutical Industries's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do TEVA's debt ratios indicate?
The financial health section shows Teva Pharmaceutical Industries's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is TEVA's dividend analysis?
The dividend section covers Teva Pharmaceutical Industries's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.